Publications

 

May 2017

Patentability of products obtained by essentially biological processes in Europe

Authors: Dr. Oliver Ladendorf, Dr. Evy Corbanie

read article

April 2016

What is the relevant date of marketing authorization to determine the term of an SPC?

Authors: Dr. Oliver Ladendorf, Dr. Alexander Kleefen

read article

April 2016

May a part of a fusion protein be considered an "active ingredient"?
Yes, says the ECJ in Forsgren

Authors: Dr. Oliver Ladendorf, Dr. Alexander Kleefen

read article

March 2016

Eli Lilly vs. HGS (C-493/12):
The UK High Court clarifies the ECJ's enigmatic decision

Authors: Dr. Oliver Ladendorf, Dr. Alexander Kleefen

read article